Cabiralizumab Antibody

SKU: orb1980657

Description

Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody that enhances antitumor immunity by promoting T cell infiltration and inhibiting osteoclast-mediated bone destruction. It has been studied in rheumatoid arthritis research and investigated in immune-oncology, including in vivo and in vitro studies for lung cancer in combination with checkpoint inhibitors.

Research Area

Signal Transduction

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	c-Fms
Molecular Weight	146.30 kDa
Purity	95.00% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	6.83 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Anti-Human CSF1R Recombinant Antibody, FPA 008, FPA008

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

c-Fms

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols